Orion Pharma (DHA:ORIONPHARM) Retained Earnings : BDT7,230 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Orion Pharma's retained earnings for the quarter that ended in Mar. 2025 was BDT7,230 Mil.

Orion Pharma's quarterly retained earnings declined from Sep. 2024 (BDT7,558 Mil) to Dec. 2024 (BDT7,222 Mil) but then increased from Dec. 2024 (BDT7,222 Mil) to Mar. 2025 (BDT7,230 Mil).

Orion Pharma's annual retained earnings increased from Jun. 2022 (BDT6,978 Mil) to Jun. 2023 (BDT7,400 Mil) and increased from Jun. 2023 (BDT7,400 Mil) to Jun. 2024 (BDT7,499 Mil).

Orion Pharma Retained Earnings Historical Data

The historical data trend for Orion Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Retained Earnings Chart

Orion Pharma Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Retained Earnings

Get a 7-Day Free Trial

5,670.24

6,400.99

6,977.54

7,400.33

7,499.34

Orion Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Retained Earnings	Get a 7-Day Free Trial															7,563.82	7,499.34	7,557.99	7,222.35	7,229.70

Orion Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Orion Pharma (DHA:ORIONPHARM) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines